The role of aberrant protein modifications in cancer and its diagnosis have emerged as a promising research field. Nonenzymatic glyco-oxidation of proteins under oxidative stress has been associated with carcinogenesis through advanced glycation end products (AGE)-receptors for advanced glycation end products (RAGE) axis. Modified proteins that are immunogenic and stimulate cellular and humoral immune responses are being studied to develop early detection markers of cancer. This study has probed the structural alternations; leading to the formation of adducts and aggregates, in histone H2A upon in vitro modification by methylglyoxal (MG). The immunogenicity of modified histone H2A and its binding with cancer autoantibodies was also assessed. MG induced lysine side chain modifications, blocking of free amino groups and the formation of condensed cross structures in histone H2A; and its effect was inhibited by carbonyl scavengers. It led to the adduct formation and generation of N-epsilon-(carboxyethyl)lysine (CEL) and its decomposition forms as revealed by Matrix-assisted laser desorption ionization-mass spectrometry, high-performance liquid chromatography and LC-MS. MG-H2A showed amorphous aggregate formation under electron microscopy and altered binding with DNA in circular dichroism studies. The modified histone elicited high titer immunogen-specific antibodies in rabbits when compared with the native, thus pointing toward the generation of neo-epitopes in MG-H2A. The autoantibodies derived from cancer patients exhibited enhanced binding with MG-H2A as compared with the native histone in enzyme-linked immunosorbent assay and gel retardation assay. This reflects sharing of epitopes on MG-H2A and histones in cancer patients. The neo-epitopes on H2A may be responsible for induction and elevated levels of antibodies in cancer patients. Thus, MG-H2A may be considered as potential antigenic candidate for auto-immune response in cancer.
Introduction
The role of advanced glycation end products (AGE)-receptors for advanced glycation end products (RAGE) axis in the cancer development and its diagnosis is emerging as a promising field of research aimed at finding the ways for early prediction of cancer and the future therapeutics (Bhawal et al. 2005) . The nonenzymatically glycated protein derivatives that accumulate in various tissues in disorders such as diabetes have been widely implicated in the biology of human cancer (Kuniyasu et al. 2003; van Heijst et al. 2005; Takino et al. 2010; Wu et al. 2010 ). The RAGE products-the multi-ligand member of the immunoglobulin super-family of cell surface molecules are known to act as factors regulating cancer cell invasion and metastasis (Sasahira et al. 2007; Kim et al. 2008) . Furthermore, the increased glucose uptake and a high rate of glycolysis leading to nonenzymatic glycation of proteins in cancers link AGE-RAGE system with the carcinogenesis (Abe et al. 2004, Abe and Yamagishi 2008) .
Post-translational modifications in the highly conserved basic core histone proteins are known to induce changes in their structural integrity and also alter their amino acid sequence, and thereby generating neo-epitopes leading to an aggressive auto-immune response (Khan et al. 2009 ). The earlier studies on AGEs and their immunogenicity have also shown AGE-modified proteins acting as endogenous source of innate epitopes recognized by natural antibodies (Chikazawa et al. 2013) . Since cancer-associated circulating autoantibodies against protein post-translational modifications are emerging as promising biomarkers for the early detection of cancer, there exists a possibility of autoantibodies against glycated histone proteins in the cancer patients, which may have a significant diagnostic relevance (Wandall et al. 2010) . Already, efforts have started to detect autoantibodies presented against aberrantly processed proteins in cancer that are immunogenic and stimulate cellular and humoral immune response on similar lines as that for rheumatoid arthritis, wherein anti-immunogIobulin G (IgG) antibodies have been reported as a diagnostic biomarker (Soussi 2000) . There is always a possibility of a breakthrough. Histone H2A being an important constituent of the core histone octamer that has tripartite organization with central (H3-H4) 2 tetramer flanked by two H2A-H2B dimmers (Arents et al. 1991) , making H2A more prone to modification, and hence our choice to study the glyoxidation. Glycation studies have been performed on histone H1 and H2B that have projected alteration in chromatin structure with severe consequences for the maintenance of genomic integrity, ultimately contributing to chronic changes associated with various diseases (Guedes et al. 2011; Pashikanti et al. 2011) . Histone H2A was chosen for this study as we could not find major reports on the glyoxidative modification of this histone.
To probe the role of glycated histone H2A in the induction of auto-immune response in human cancers, histone H2A was glycated by a highly reactive electrophile, methylglyoxal (MG) that can modify the proteins at physiological concentration (Lo et al. 1994 ) and at higher concentrations as well (Mir et al. 2014) . MG is known to react with amino and sulfhydryl groups of proteins like bovine serum albumin, glycolytic enzymes, collagen, lysozyme, insulin, red blood cell membrane proteins, hemoglobin, myoglobin and lens alpha-crystallins, leading to the formation of advanced glycation end products (AGEs). The AGEs have been associated with various diseases such as diabetes, cataractous lens and neurodegenerative disorders. The role of AGEs has been also highlighted in physiological aging (Lo et al. 1994; Chellan and Nagaraj 1999; Kuhla et al. 2005; Beranek et al. 2006; Yuen et al. 2010; Oliveira et al. 2011) .
In this study, histone H2A was incubated with 7.5 mM of MG and incubated for 24 h at 37°C. The MG-mediated modifications in histone H2A were studied by 2,4,6-trinitrobenzene sulfonic acid (TNBS) assay, reaction with carbonyl scavengers, Thioflavin T (ThT) fluorescence assay, high-performance liquid chromatography (HPLC), liquid chromatography-mass spectrometry (m/z analysis), matrix-assisted laser desorption ionization-mass spectrometry (MALDI-MS), scanning electron microscopy (SEM) and through the altered binding interactions with DNA using circular dichroism (CD) analysis. The immunogenicity of native H2A and MG-H2A was probed by immunizing rabbits, and the binding patterns of histones against the corresponding antibodies generated were studied by direct binding ELISA, competitive inhibition studies and gel retardation assay. Circulating autoantibodies present in patients with various types of cancers were also assessed for their binding to native and MG-H2A.
Results

Determination of free amino groups using TNBS
The free ε-amino groups in native H2A and MG-H2A were found to be 29.8 ± 1.1 and 7.1 ± 0.46 nmol/mg, respectively, which corresponds to a 76.1% decrease in free amino groups upon modification.
Studies on effect of carbonyl scavengers on MG modification of histone H2A
Carbonyl scavengers, penicillamine and aminoguanidine led to a significant decrease in AGE-specific fluorescence of MG-H2A. The fluorescence intensity given by MG-H2A alone, and MG-H2A incubated with penicillamine and aminoguanidine were 36.37, 14.82, and 17.38 respectively, which correspond to 59.24 and 52.21% reduction in fluorescence intensity of MG-H2A by penicillamine and aminoguanidine, respectively. The results are shown in Figure 1 .
ThT fluorescence studies
The observed fluorescence intensities for native and modified histone H2A under identical conditions were 24.079 at 495 nm and 49.236 at 497 nm, respectively, which corresponds to 51.6% enhancement in fluorescence intensity in the modified histone H2A. The results are presented in Figure 2 . 
Detection of N-epsilon-(carboxyethyl)lysine by HPLC analysis
The chromatogram of standard N-epsilon-(carboxyethyl)lysine (CEL), used as reference, showed a well-defined peak with a retention time of 14.56 min ( Figure 3A ). The hydrolysate of native protein showed no peak at the retention time observed for CEL ( Figure 3B ). However, the hydrolysate of MG-modified H2A gave a well-defined peak at 14.42 min ( Figure 3C ).
m/z analysis by LC-MS
LC-MS spectra showed a base peak and two product-ion mass peaks at m/z values of 219.0145 and, 84.1024 and 130.1032, respectively, for standard CEL ( Figure 4A ). Under the same conditions, hydrolysate of native histone H2A gave no such specific peak ( Figure 4B ). However, the MG-modified form of the histone exhibited three peaks (base peak and two product-ion peaks) similar to that of standard CML. Of the three peaks, the most prominent ion product appeared at m/z of 84.1203. The less intense peaks were observed at m/z of 130.1245 and 219.1327 ( Figure 4C ).
Detection of CML by MALDI
MALDI analysis, performed to study attachment of MG residues to the histone H2A, showed two obvious peaks for native histone H2A at m/z ratio of 7048 and 14,109 ( Figure 5A ). However, modified histone gave distinct peaks at 7192 and 14,613 ( Figure 5B ).
SEM
Scanning electron microscopic images of native ( Figure 6A ) and MG-H2A ( Figure 6B ) appeared quite different from each other as native H2A presented granular images, while MG-H2A formed amorphous aggregates.
CD analysis of DNA-protein interactions
The circular dichroic spectral analysis of interactions between histone H2A and DNA showed marked variations in spectral properties of native histone, its modified form and the native DNA. Native DNA showed a positive band at 277 nm (θ = 8.542) and a negative band at 243 nm (θ = 5.851). The interactions between histone H2A with DNA lead to decrease in the positive peak at 276 (θ = 5.133) and an increase in the negative peak at 245 (θ = 4.642). The CD results for MG-modified histone and DNA interactions were different from DNA and H2A-DNA. For MG-H2A-DNA, we observed an intermediate peak at 276 (θ = 5.423) and an increase in the negative peak at 243 (θ = 4.315), respectively ( Figure 7 ).
Immunogenicity of native and MG-modified histone H2A
A moderate antibody response was observed for native H2A ( Figure 8A ). Antiserum against MG-H2A showed an antibody titer of >1:12,800 ( Figure 8B ). Yeast RNA used as carrier was nonimmunogenic, when checked in a different set of animals (data not shown).
In competitive-inhibition ELISA, 37.3% inhibition of anti-native H2A antibodies binding was caused by native H2A ( Figure 9A ). However, 69.3% inhibition in the binding of anti-MG-H2A antibodies was observed when the immunogen was employed as inhibitor with 50% reduction in antibody activity at an inhibitor concentration of 5.2 μg/mL ( Figure 9B ).
Purification and characterization of serum IgG
IgG, derived from the rabbit sera immunized with native H2A and MG-H2A, eluted as a single symmetrical peak and presented a single homogeneous band in SDS-PAGE. The purified IgGs showed strong binding with their respective immunogens in the direct binding ELISA. The saturation for native and MG-H2A was obtained at 60 and 40 μg/mL of the respective IgG. However, the preimmune IgG showed negligible binding under identical conditions (data not shown).
In competitive-inhibition ELISA, anti-native H2A IgG exhibited 72.9% inhibition in the antibody binding with native H2A as inhibitor; 50% inhibition was achieved at 5.1 μg/mL of the inhibitor ( Figure 9C ). However, for anti-MG-H2A antibodies, 89.9% inhibition in the antibody binding was achieved when the modified H2A was employed as inhibitor with 50% reduction in antibody activity at an inhibitor concentration of 1.9 μg/mL ( Figure 9D ).
Cross reactivity of anti-native-H2A IgG and anti-MG-H2A IgG with various inhibitors
The antibodies (IgG) induced against native and MG-H2A showed cross reactivity with various inhibitors. A maximum inhibition of 89.9% in the activity of anti-MG-H2A IgG was caused when the immunogen was used as inhibitor. However, native histone H2A caused a maximum inhibition of 52.9% in the binding of anti-MG-H2A IgG. Anti-native H2A IgG caused a maximum inhibition of 72.9% when the immunogen was used as inhibitor. MG-H2A caused a maximum inhibition of 49.3% in the binding with anti-native H2A IgG. The binding of anti-native H2A IgG and anti-MG H2A IgG was also analyzed with native and MG-modified forms of various amino acids and proteins, viz lysine, phenylalanine, arginine, poly-L-lysine, human serum albumin, histone H1, histone H3 and human IgG. The details of binding patterns of various inhibitors, their maximum percent inhibitions, the observed concentrations for 50% inhibition and percent relative affinities have been summarized in the Tables I  and II. Gel retardation assay SDS-PAGE results showed a slight mobility shift for native H2A when incubated with anti-MG-H2A IgG ( Figure 10A ). However, incubation of MG-H2A with increasing concentrations of the IgG resulted in proportional increase in the formation of high molecular mass immune complex and a consequent mobility shift of MG-H2A. Consequently, a gradual decrease in the intensity of free MG-H2A was observed ( Figure 10B ).
Binding of serum autoantibodies in cancer patients to native H2A and MG-H2A Significantly higher percentage of serum autoantibodies from all cancer types showed enhanced binding with MG-H2A as compared with the native form in the direct binding ELISA. Out of the total 80 serum samples, 48 samples (60%) exhibited appreciably higher binding to the MG-H2A as against its native counterpart. These include 16 samples of lung cancers, 9 samples of gall bladder, 12 samples of prostate cancers and 11 samples of esophageal and gastric cancer patients. The results are presented in Figure 11A -D.
Binding of IgG from cancer patients to native H2A and MG-H2A
To further evaluate the fine specificity of autoantibodies in cancer patients, IgG was isolated from serum samples showing higher binding toward MG-H2A and evaluated by inhibition ELISA. IgG was mixed with varying amounts of native and MG-H2A (0-20 μg/mL) and incubated for 2 h at 37°C and overnight at 4°C. The observed antibody inhibition for native H2A and MG-H2A histones was in the range of 16.9-41.5% and 49.3-73.3%, respectively. The mean percent inhibition by native H2A in the binding of autoantibodies from lung, gall bladder, prostate and esophageal and gastric cancer patients was 25.26 ± 7.04, 22.8 ± 6.7, 30.5 ± 5.4 and 25.81 ± 6.11, respectively; however when MG-H2A was used as an inhibitor, the antibody activity was inhibited by 66.77 ± 9.37, 53.9 ± 4.6, 63.92 ± 7 and 60.3 ± 11.7, respectively. Data are presented in Table III .
Discussion
With the emergence of large number of evidence on the correlation of AGE-RAGE axis with cancers, various studies have provided insights in the likeliness of diabetes patients having cancer (Kuniyasu et al. 2003; van Heijst et al. 2005; Takino et al. 2010; Wu et al. 2010) . It has also been reported that the cancers are associated with higher glucose uptake and the consequent formation of AGEs, which through the sustenance of the oxidative burst and binding with V-domain of RAGE, contribute to cancer growth. Glycation adducts like glucosederived AGE CML and the MG-derived AGE argpyrimidine have been found at different expression levels in various cancer tissues and have been implicated in the biology of cancer (Abe et al. 2004, Abe and Yamagishi 2008) . The AGEs are known to stimulate an antibody response like other post-translational modifications and may have direct relevance to cancer therapeutics because many of these antigens are also involved in cell-mediated immune reactions, which is the principal mechanism for tumor immunity (Kang et al. 2010) .
Among the proteins, various types of post-translational modifications of histones in particular have been attributed with an important role in gene expression and consequently in cancer development and progression, and their modifications are also being explored as potential biomarkers of cancer progression and prognosis (Luo et al. 2011; Chervona and Costa 2012) . However, glyco-oxidation of histone proteins and their association with autoantibody generation in cancer is still unexplored. This study was aimed to probe the role of MG on the structural characteristics of histone protein H2A and its immunogenicity. Furthermore, we probed the presence of autoantibodies against the glycated histone in sera of the patients with various types of cancers. Histone H2A showed conformational changes, generation of AGEs and aggregate formation upon MG modification. Modified histone was highly immunogenic and cancer patients harbored autoantibodies against it.
TNBS assay showed a considerable blocking of free amino groups and lysine side chain modifications in histone H2A upon MG-mediated modification. Strong inhibitory effects of carbonyl scavengers, penicillamine and aminoguanidine upon MG-mediated histone glyco-oxidation led to the quenching in fluorescence intensity of MG-H2A.
The 51.6% increment in the ThT fluorescence intensity of modified histone H2A compared with its native counterpart shows theformation of condensed cross structures in histone H2A upon modification leading to enhanced ThT binding and more fluorescence intensity. This is in conformity with earlier studies showing glycationinduced formation of unstructured aggregates in proteins due to enhanced binding with ThT (Ghosh et al. 2013) . Since enhanced ThT binding affinity is associated with intra-molecular β-sheet structures and fibril and amyloid aggregation, only mild increase in the ThT binding affinity may point toward amorphous nonfibril protein aggregate formation.
HPLC analysis showed a co-migration of acid hydrolyzed MG-H2A with the standard CEL, thus pointing toward the MG-mediated generation of CEL. The absence of any such peak in case of native protein confirms that CEL formation is due to glyoxidation reaction of MG with the histone H2A. Earlier studies have shown the formation of CEL, methylglyoxal lysine dimer (MOLD) and argpyrimidine, a fluorescent arginine modification product formed during the reaction of MG with various model compounds and in the proteins such as RNAse, human lens proteins, bovine α-crystallin and collagen (Nagaraj et al. 1996; Ahmed et al. 1997; Padayatti et al. 2001) . Besides MG many pentoses, ascorbate and other sugars have also been found to generate CEL (Ahmed et al. 1997) . In an earlier report on histone H1, carboxymethyl lysine generation in the N-terminal region of the sequence of histone H1 close to its globular domain was observed (Pashikanti et al. 2011) .
Mass spectrometry confirmed the generation of carboxyethylated lysine residues and their decomposition by the applied collision energy in the MG-modified histone. The spectra for MG-H2A and standard CEL gave base peaks and two product-ion mass spectra on the similar positions. No such peaks were presented by their native counterparts thus showing the absence of carboxyethylated lysine residues in their unmodified forms. Earlier studies have shown the generation of adducts like imidazolium cross-link structure, imidazolysine and CEL by dicarbonyl compounds (Wells-Knecht et al. 1995; Ahmed et al. 1997) . Histone H2B and H1 modified by glucose in pseudophysiological conditions have been reported with 14 and 6 possible glycation sites, respectively (Guedes et al. 2011 ). On the similar pattern, histone H2A may be modified at various positions.
MALDI-MS results for native and modified forms of histone H2A showed the generation of two obvious peaks thus signaling the presence of protein molecules with single and double charges. In case of histone H2A, the peaks shift from m/z ratio of 7048 and 14,109 in the native H2A to the m/z ratio of 7192 and 14,613 in the MG-modified H2A shows an increment in mass values by 648 Da, which corresponds to the attachment of 9 residues of MG. Earlier reports on MALDI analysis of various proteins such as human serum albumin, human IgG, lysozyme, and insulin have shown the attachment of MG residues to proteins upon nonenzymatic glycation reaction (Oliveira et al. 2011; Pampati et al. 2011) .
SEM has revealed the microarchitectural details and morphological characteristics of various glycated proteins, wherein the formation of different types of aggregates upon modification by various sugars and their derivatives have been reported (Bouma et al. 2003; Iram et al. 2013) . Native histone H2A appeared as small networked threads under SEM. However, the modified form presented an aggregate form, in conformity with the earlier observation of aggregate formation upon glycation of histones. Also, histones after modification gave more like an amorphous structure. Since histone H2A acquires α and β structures and forms aggregates upon MG-mediated glycation, and also shows mild binding with ThT, it appears that amorphous microstructure is the preferred form of modified histone. These amorphous aggregates could have a pathological significance as earlier studies have shown them to be cytotoxic in comparison to the fibrillar morphology (Bucciantini et al. 2002; Ishimaru et al. 2003) . The formation of various types of structures such as globular and amorphous aggregates, irregularly shaped sheets with varying sizes, clustered granular precipitates and large branched chains have been reported for various proteins like human serum albumin, hen egg white lysozyme and hemoglobin after glycation by sugars like glucose, glyceraldehyde and fructose (Ishimaru et al. 2003; Iram et al. 2013) . The electron microscopic studies thus show the formation of diverse types of shapes after glycation, and these variable shapes may have pathological relevance.
Histone H2A is a part of the core histone octamer, and it has specific properties for binding with DNA. However, MG modification led to a change in its characteristic cooperative binding with DNA. The MG-H2A-DNA spectrum points toward the structural damage of histone protein leading to decreased interactions of H2A with DNA. The observed intermediate spectra may be a consequence of the presence of mixtures of bound and free DNA in solution due to incomplete complex formation between modified histones and DNA. The results confirm that the glycated histones behave differently from their native forms.
The possible generation of neo-epitopes on histone H2A upon modification by MG and the changes in its antigenic characteristics were yet another focus of this study. Histone proteins are known to be weak immunogens that fail to induce stronger immune response due to their conserved nature. The characteristic antigenic properties of histones get changed as a result of various types of post-translational structural alterations that alter the amino acid sequence or change the secondary and tertiary structural patterns of histone proteins, consequently producing new antigenic determinants on the protein molecules, which eventually cause a stronger auto-immune response.
The immunogenicity of histone H2A and its modified form were evaluated by inducing antibodies in rabbits. Native H2A failed to generate a potential immune response as it induced low titer antibodies. However, MG-mediated alterations conferred antigenic properties to histone H2A leading to a strong response from the rabbit immune system resulting in high titer antibodies against the modified histone. The post-modification enhancement in the immunogenicity of histones has been earlier reported in the case of peroxynitrite-modified histones, which induced an autoaggressive immune attack (Khan et al. 2009 ).
Higher specificity of the anti-MG-H2A antibodies toward the immunogen as against the anti-H2A antibodies for the native H2A points toward the generation of neo-epitopes on histones upon modification by MG that has eventually conferred it with enhanced immunogenicity and specificity. Earlier studies have also demonstrated that AGEs potentially induce stronger and specific immune response (Ikeda et al. 1996; Takeuchi et al. 2000; Ahmad et al. 2012) . Our results, showing enhanced immunogenicity of H2A upon MG modification, therefore, conform to the earlier reports.
The possible sharing of the epitopes with a set of amino acids and proteins was elucidated by cross reaction studies. It was observed that anti-MG-H2A IgG was appreciably recognized by MG-modified forms of human serum albumin, histone H1 and H3, lysine, poly-L-lysine, human IgG, arginine and phenylalanine. The native counterparts of these inhibitors showed lesser binding toward the antibodies generated against modified histone H2A. The same inhibitors when checked for their binding with the anti-native-H2A IgG showed significantly lesser binding. It may be inferred from the cross reaction studies that histone H2A, in both its native and MG-modified form elicit poly-specific antibodies with cross-reactive tendencies against a wide range of inhibitors that share some antigenic determinants. Furthermore, it appears that modification has not totally destroyed the old epitopes in the histones instead some of them are retained and are recognized by anti-native antibodies. These studies projects lysine having a prominent role in presenting neo-epitopes, as MG-modified lysine was found to cause highest inhibition of the anti-MG-H2A antibodies. Earlier studies have shown AGE-modified proteins, peptides and lysine derivatives presenting common epitopes suggesting a similarity in AGE structures (Ikeda et al. 1996; Arif et al. 2012; Ahmad et al. 2012) .
The ELISA results were further confirmed by the gel retardation studies. An appreciable decrease in the unbound antigen and the formation of high molecular mass immune complex between MG-H2A with increasing concentration of IgG proves stronger binding of MG-modified H2A with the IgG. Loss in the intensity of dimer-specific bands may be due to the presence of dimer-specific antibody population. As in the competitive-inhibition ELISA, native H2A showed lesser binding with the anti-H2A IgG in gel retardation also.
Appreciably higher binding of serum antibodies from cancer patients to the MG-H2A as compared with native histone reflects the enhanced recognition of epitopes on MG-modified histone by circulating autoantibodies from various cancer types. This shows the presence of MG-H2A-like epitopes in cancer patients against which the immune system produces antibodies as these epitopes are not recognized as "self".
Competitive inhibition binding studies further confirmed the better recognition of MG-H2A by cancer autoantibodies, as these antibodies were inhibited 16.9-41.5% by native histone H2A, and 49.3-73.3% by MG-H2A. Various studies have provided insights about the potential future use of autoantibodies as biomarkers of early-stage cancers (Lacombe et al. 2014) . This study makes a scope for a possible role of autoantibodies against the modified epitopes on glycated histones in the detection of cancers.
Conclusion
In conclusion, we report MG as a strong glycating agent that alters the structural characteristics of histone H2A, a nuclear histone core Table III 2, 4, 5, 7, 8, 10, 12, 15, 16, 18, 19, 22, 23, 26, 27 26.3, 23.3, 32.1, 27.3, 20.7, 27.6, 25.4, 23.2, 31.9, 22.1, 24.5, 27.2, 25.5, 28.4, 32.3, 26.5 62.8, 67.9, 71.8, 64.7, 73.3, 73.2, 51.8, 64.8, 57.8, 71.4, 66.2, 68.9, 55.6, 71.3, 72.4, 69.7 25.26 ± 7.04
66.77 ± 9.37
Gall bladder cancer 28, 32, 33, 34, 35, 37, 39, 41, 42 26.6, 29.5, 27.8, 23.7, 25.4, 25.6, 23.8, 16.9, 24.7 54.2, 54.9, 53.7, 50.8, 58.2, 52.7, 49.3, 58.4, 52.9 22.8 ± 6.7
53.9 ± 4.6
Prostate cancer 44, 46, 47, 49, 50, 51, 52, 54, 55, 57, 59, 61 35.9, 41.1, 41.5, 35.5, 27.1, 33.4, 27.5, 25.9, 35.2, 29.2, 27.4, 33.9 58.8, 65.5, 71.2, 63.5, 52.4, 65.2, 65.2, 63.1, 72.3, 66.4, 54.4, 69.1 30.5 ± 5.4 63.92 ± 7.22
Esophageal and gastric cancer 64, 66, 67, 68, 69, 70, 72, 74, 76, 77, 79 27.8, 28.2, 24.8, 24.8, 31.2, 25.3, 24.2, 24.2, 28.3, 19.7, 25.4 69.1, 64.3, 58.1, 56.1, 59.3, 53.2, 59.4, 65.1, 48.6, 67.4, 62.7 25.81 ± 6.11 60.3 ± 11.7 component. The damage caused by MG is not limited to extracellular and intracellular proteins alone, as it was believed earlier.
MG-induced structural changes generate neo-epitopes on histone H2A that markedly enhance its immunogenicity, leading to the induction of specific antibody response in rabbits. The stronger binding of modified H2A with the autoantibodies derived from cancer patients point toward similar modifications, in vivo, in cancer patients leading to a strong immune response, which may have a diagnostic utility. The study is significant as the search of biomarkers for the early detection of cancer is emerging as a prime focus of research.
Experimental methodologies
Determination of the protein concentration of histone H2A
Molar extinction coefficient of calf thymus histone H2A (3850 M
) was used to determine the concentration of the protein by measuring the absorbance of protein solutions at 280 nm. The molecular mass of calf thymus histone H2A used for calculations was 14,004 Da.
Modification of H2A histone by MG
The procedure of Roberts et al. was followed for the modification of histone H2A (Roberts et al. 2003) . Histone H2A (42 µM) was incubated with 7.5 mM MG in phosphate buffer saline (PBS) (10 mM sodium phosphate buffer, pH 7.4 containing 150 mM NaCl) for 24 h at 37°C. All the samples were extensively dialyzed after incubation.
Determination of free amino groups using TNBS
The free ε-amino groups in the native and MG-H2A were estimated by TNBS assay (2,4,6-trinitrobenzene sulfonic acid) (Kale and Bajaj 2010) . Absorbance was recorded at 335 nm, and the concentration of ε-amino groups was determined using molecular mass and molar extinction coefficients of histone H2A.
Percent glycation of amino groups was calculated as Percent glycation of amino groups ¼ ðamount of ε À amino group in native histoneÞÀ amount of ε À amino group in glycated histoneÞ amount of ε À amino group in native histone:
Studies on effect of carbonyl scavengers on MG modification of histones
The quenching effect of carbonyl scavengers on MG-H2A was studied by incubating 7.5 mM of MG with 4 mM of penicillamine and aminoguanidine in 10 mM PBS, pH 7.4 for 24 h, and the emission fluorescence intensity was recorded at 440 nm after exciting at 370 nm. The percent fluorescence quenching was calculated and compared with control, the histone samples without modifying agent.
ThT fluorescence assay
Protein aggregation was studied as per the established protocol of ThT fluorescence assay (Hudson et al. 2009 ). The molar ratio of histone H2A and ThT was taken as 1:2, and the emission spectra were recorded between 400 and 600 nm after exciting at 440 nm. The concentration of ThT was determined using extinction coefficient of 36,000 M −1 cm Detection of CEL by HPLC analysis CEL detection in the native H2A and MG-H2A was carried out through HPLC analysis. The proteins were first hydrolyzed with 6 M HCl at 110°C for 12 h and subjected to ultrafiltration through 0.42 μM Millex filter. The hydrolysate was subjected to chromatography on a 1.0 mL cation-exchange column (sulfonic acid, SP-Sephadex C25) followed by a 1.0 mL anion-exchange column (ammonium, Dowex X8-100). HPLC was performed using a C18 reverse-phase Xterra column (3.0 × 250 mm, particle size 5 μm) with a flow rate of 1 mL/min, and the Agilent fluorescence was monitored by excitation at 340 nm and emission at 450 nm as described earlier (Pashikanti et al. 2011) . The retention time of commercially available CEL (Sigma) was taken as reference.
Liquid chromatography mass spectrometry (m/z analysis)
The HPLC system was connected to a time-of-flight mass spectrometer (LC-MS-IT-TOF, Shimadzu) equipped with an electrospray interface that was operated in a positive ion mode. Full scan MS analysis was carried out in the range of 0-240 m/z ratio. The MS result of commercially available CEL (Sigma) was taken as reference .
MALDI-MS analysis
MALDI-MS studies were carried out on a Protein Chip System (Ciphergen Biosystems, Copenhagen, Denmark) operating in the positive linear mode. Sinapinic acid, dissolved in acetonitrile-water (50:50, v/v) at a concentration of 50 mM, was used as the matrix. Samples for measurement were dissolved in 0.1% formic acid at a concentration of ∼0.1 mg/mL. Equal amounts of sample and matrix solutions were added, and ∼1-2 µL of the mixture was deposited on the gold plate and allowed to dry before introduction into the mass spectrometer. Analysis was done using the protein chip software (Pampati et al. 2011) .
SEM studies
The microarchitectural details of native H2A and MG-H2A were observed using SEM. Air dried samples adsorbed onto cellulose ultrafiltration membrane were coated with gold and mounted on a carbon tape-coated stainless steel grids operating on an accelerating voltage of 15 kV and under low vacuum conditions. The images were taken using a JSM-6510LV (JEOL JAPAN) scanning electron microscope (Iram et al. 2013 ).
Study of interactions with DNA by CD analysis
The differences in the DNA binding properties of native H2A and MG-H2A were analyzed by CD spectroscopy. Furthermore, 50 μg/mL of DNA was incubated for 1 h with 0.2 mg/mL of native H2A and MG-H2A, respectively, in 0.05 M Tris buffer, pH 7.4. The samples were subjected to centrifugation at 14,000 rpm for 8 min, and CD spectra were recorded between 220 and 300 cm −1 for the supernatant.
Native DNA of the same concentration was taken as control (Chikhirzhina et al. 2012 ).
Immunization schedule
Randomly bred female New Zealand white rabbits weighing 1-1.5 kg were selected for immunization as per an established protocol (Ali and Alam 2002) . Native H2A and MG-H2A (200 µg) complexed with yeast RNA emulsified with equal volume of Freund's complete adjuvant for the first injection and with Freund's incomplete adjuvant for the next five doses were intramuscularly injected into animals at weekly intervals. Blood was collected after the last dose and the sera were separated. The complement proteins were inactivated at 56°C for 30 min, and the sera was stored at −20°C with 0.1% sodium azide as preservative. The study protocol had the required ethical clearance.
Isolation of IgG by affinity chromatography
Serum immunoglobulin G (IgG) was isolated from the experimental animals by affinity chromatography on a protein A-agarose column (Ahmad et al. 2011 ). The IgG concentration was determined considering 1.4 OD 280 = 1.0 mg IgG/mL. The isolated IgG was dialyzed against PBS and stored at −20°C with 0.1% sodium azide.
Immunological detection of antibodies
Preimmune and immune sera were tested for antibodies against native and MG-modified histones by enzyme-linked immunosorbent assay (ELISA) and gel retardation assay.
Direct binding ELISA
ELISA was carried out on flat bottom polystryrene modules as described earlier (Ali and Alam 2002) . Polystryrene polysorp microtiter wells were coated with 100 µL of native or MG-modified proteins (10 µg/mL). The absorbance (A) of each well was monitored at 410 nm on an automatic microplate reader. Each sample was run in duplicate, and the results were expressed as the mean of two readings.
Competition ELISA
The antigenic specificity of the antibodies was determined by competition ELISA (Ahmad et al. 2011) . Varying amounts of inhibitors (0-20 μg/mL) were mixed with a constant amount of affinity purified IgG, and the mixture was incubated at room temperature for 2 h and overnight at 4°C. The immune complex thus formed was coated in the wells in place of the IgG. The remaining steps were the same as in direct binding ELISA (Ali and Alam 2002) . Percent inhibition was calculated using the formula
Cross-reactivity studies with various inhibitors Antigenic specificity of antibodies against native and modified histones with various inhibitors was also ascertained by inhibition ELISA (Ali and Alam 2002) .
Band shift assay
For the visual detection of antigen-antibody binding and immune complex formation, gel retardation assay was performed (Laemilli 1970) . Immune complexes were prepared by incubating constant amount of native and MG-modified histones with varying amounts of affinity purified immune IgG in TBS for 2 h at 37°C and overnight at 4°C. One-fourth of sample dye was added to the mixture and electrophoresed on 10% PAGE for 4 h at 80 V. The gels were visualized using silver nitrate staining.
Collection of blood samples for clinical studies
In order to probe the presence of autoantibodies against native and MG-H2A, sera were obtained from cancer patients (n = 80) of different age groups attending the J.N. Medical College Hospital, Aligarh, India. The population included lung cancer patients (n = 27), patients with cancers of gall bladder (n = 16), prostate cancer (n = 19) and esophageal and gastric cancer patients (n = 18). There were 47 females with a mean age of 37.2 ± 19.5 years and 33 males with a mean age of 35.8 ± 16.4 years. The age of all the patients fell between 15 and 63 years. Samples from healthy individuals (n = 40; 20 males and 20 females with a mean age of 36 ± 18.6 years) served as control. Informed consent was obtained from all the patients and normal healthy individuals. The work had the required ethical clearance. The serum samples were heated at 56°C for 30 min to inactivate complement proteins and stored at −20°C with 0.2% sodium azide. Serum antibody binding was evaluated by ELISA.
Statistical analysis of results
All measurements were done in duplicates. Results are expressed as mean ± SD. A two-tailed P value lower than 0.05 was taken as significant.
